Clinical Trial: A Study on the Immune Response and Safety of a Combined Vaccine Against Diphtheria, Tetanus and Acellular Pertussis (dTpa) in Japanese Healthy Pregnant Women

U.S., May 20 -- ClinicalTrials.gov registry received information related to the study (NCT07596199) titled 'A Study on the Immune Response and Safety of a Combined Vaccine Against Diphtheria, Tetanus and Acellular Pertussis (dTpa) in Japanese Healthy Pregnant Women' on May 13.

Brief Summary: The purpose of this Phase 3, non-randomized, single-arm, open-label study is to evaluate the immune response, reactogenicity and safety of GSKs dTpa vaccine in Japanese pregnant women between 27 weeks and less than 37 weeks of pregnancy. Both the pregnant women and their neonates born during the study will be evaluated for specific analyses.

Study Start Date: June 29

Study Type: INTERVENTIONAL

Condition: Diphtheria-Tetanus-acellular Pertussis Vacci...